Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for prevention of colorectal sporadic adenomatous polyps
NCT00141193Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2001
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 32
01
Overview
Phase 3, randomised, double-blind trial in Colorectal Adenoma (CRA) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Proportion of subjects with new colorectal adenomas post baseline polypectomy at Month 37. Started Feb 2001; status: completed.
02
Drugs
celecoxib
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT00141193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141193.